Edwards Lifesciences names new CFO to succeed Scott Ullem

Edwards Lifesciences (NYSE: EW) appointed Theodora Mistras as corporate vice president and chief financial officer, effective at the end of May. Mistras will succeed Scott Ullem, who announced his planned transition from the CFO role in October.

Mistras joins Edwards from Viatris, where she served as CFO since March 2024, leading the company's global finance organization. She previously worked as a managing director in healthcare investment banking at Citigroup Global Markets and held senior leadership roles in healthcare investment banking at Goldman Sachs.

Mistras holds a bachelor's degree in international studies from the University of Pennsylvania and a bachelor's degree in economics from the Wharton School.

"We are very pleased to welcome Doretta to Edwards as our next CFO," said Bernard Zovighian, Edwards' CEO. "Doretta's broad experience will be instrumental as we execute our differentiated strategy."

Ullem has served as Edwards' CFO since 2014. "We would like to once again thank Scott for his outstanding leadership, partnership and impact," Zovighian said. "His commitment to a thoughtful transition and his continued support as a strategic advisor in the months ahead reflects the discipline and continuity that have long defined Edwards' approach to leadership."

Edwards Lifesciences is a structural heart innovation company based in Irvine, California. The information is based on a company press release.

You May Also Be Interested In

• Apollo Global Management (APO) call put ratio 1 call to 6.8 puts a focus on a spreader of 9K contracts January 95 and 135 puts
• Meta Platforms (META) call put ratio 1.7 calls to 1 put
• Gil Issachar steps down as CTO at Firefly Neuroscience